DailyFinance  9 hrs ago  Comment 
MADISON HEIGHTS, MI -- (Marketwired) -- 09/19/14 -- Creative Edge Nutrition, Inc. (PINKSHEETS: FITX), CEN Biotech Inc., today announced that it will be offering a Question & Answer Open House for Residents of Lakeshore. Details are as...
SeekingAlpha  Sep 19  Comment 
By Bret Jensen: As a regular columnist on Real Money Pro, a frequent contributor here on SeekingAlpha and being the editor of the recently launched monthly newsletter Small Cap Gems, I get a lot of questions from investors on a daily basis. I try...
FierceBiotech  Sep 19  Comment 
The U.S. boom in biotech IPOs has largely failed to drift across the Atlantic and galvanize many floats in Europe, but France's OSE Pharma is looking to buck that trend in hopes of bankrolling late-stage studies for its immuno-oncology candidate.
DailyFinance  Sep 19  Comment 
YONKERS, NEW YORK -- (Marketwired) -- 09/19/14 -- ContraFect Corporation(NASDAQ: CFRX) (NASDAQ: CFRXW) (NASDAQ: CFRXZ), a biotechnology company focused on protein and antibody therapeutic products for life-threatening infectious diseases,...
Financial Times  Sep 18  Comment 
Almost $4bn has been raised by US biotech groups in IPOs and follow-on fundraisings this year, while in Europe the comparable figure is $1.4bn
FierceBiotech  Sep 18  Comment 
The German biotech says it will take legal action against Andromeda for the damages that have resulted. And this dust-up has only just begun. More litigation is all but guaranteed.
FierceBiotech  Sep 18  Comment 
For evidence of Wall Street's ongoing hesitance to embrace biotech startups, look no further than ProQR Therapeutics and Foamix Pharmaceuticals, two IPO debutantes with diametric fortunes on the market.
Motley Fool  Sep 18  Comment 
Gilead Sciences, Celgene Corp, and BioMarin are three biotech industry companies that are revolutionizing how doctors treat patients.
FierceBiotech  Sep 18  Comment 
A little more than two months after inking a licensing deal with Sanofi, CureVac has completed another tie-up, banking a $45 million upfront from Boehringer Ingelheim and partnering its therapeutic vaccine aimed at lung cancer. The deal also...
DailyFinance  Sep 17  Comment 
LOS ANGELES, CA -- (Marketwired) -- 09/17/14 -- MMRGlobal, Inc. (OTCQB: MMRF) ("MMR" or the "Company") today announced that it has received another significant milestone payment pursuant to an existing Non-Exclusive License Agreement (the...


Related Articles


Biotechnology is the use of molecular biology and genetic engineering techniques to develop treatments for human diseases. Many leading companies from the industry originated in the late 70's from university research laboratories. In the 1980s after attracting venture investors and after listed in the US stock exchange,have then developed into a growing industry that uses research innovations to develop new agricultural products, biomedical tools, and human therapies such as monoclonal antibody for cancer. In 2006, 92% of employees in the biotechnology industry worked in companies that specialized in developing new drugs or medical devices and equipment, while 8% were employed in companies that specialized in agricultural products. [1] The large cap company in the group is Amgen, Genentech, Biogen-Idec, Genzyme. iShares Nasdaq Biotechnology (IBB) offers a low risk/reward investment vehicle for long term investors

Industry Information

Major Biotechnology Companies

ISTA Pharmaceuticals (ISTA)

Biotechnology Industry Trends & Forces

High Pipeline Risk for New Drugs

Dependence on Health Insurance/Medicare Coverage

Dependence on Governmental Regulations

High Volatility and Instability at Start-up

Litigation Risk

Market Share


  1. State Bioscience Initiatives 2008 Report, published by the Biotechnology Industry Organization

Top Ten/Twenty Best Selling Drugs 2009

M&A Biotechnology

Monoclonal Antibody Market 2009

Vaccine Market 2009

Global Monoclonal Antibodies Market Review 2008 (World Top Ten mAbs)

M&A Review: Pharmaceutical & Biotechnology Industry

Global Vaccine Market Review 2008 (World Top Ten Vaccines)

Ipilimumab (BMS) Review: A Cancer Breakthrough?

Denosumab (Prolia, Amgen) FDA Review & Approval

Companies in the Biotechnology Industry (193)

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki